144 related articles for article (PubMed ID: 3717143)
1. Factors associated with survival differences between black women and white women with cancer of the uterine corpus.
Steinhorn SC; Myers MH; Hankey BF; Pelham VF
Am J Epidemiol; 1986 Jul; 124(1):85-93. PubMed ID: 3717143
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage.
Madison T; Schottenfeld D; Baker V
Cancer; 1998 Oct; 83(8):1546-54. PubMed ID: 9781948
[TBL] [Abstract][Full Text] [Related]
3. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
Sherman ME; Devesa SS
Cancer; 2003 Jul; 98(1):176-86. PubMed ID: 12833470
[TBL] [Abstract][Full Text] [Related]
4. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
Brooks SE; Zhan M; Cote T; Baquet CR
Gynecol Oncol; 2004 Apr; 93(1):204-8. PubMed ID: 15047237
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in survival of women with endometrial cancer.
Bain RP; Greenberg RS; Chung KC
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):914-23. PubMed ID: 3674166
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time.
Wright JD; Fiorelli J; Schiff PB; Burke WM; Kansler AL; Cohen CJ; Herzog TJ
Cancer; 2009 Mar; 115(6):1276-85. PubMed ID: 19204905
[TBL] [Abstract][Full Text] [Related]
7. Affluence and Breast Cancer.
Lehrer S; Green S; Rosenzweig KE
Breast J; 2016 Sep; 22(5):564-7. PubMed ID: 27296617
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic differences account for racial disparity in uterine cancer survival.
Smotkin D; Nevadunsky NS; Harris K; Einstein MH; Yu Y; Goldberg GL
Gynecol Oncol; 2012 Dec; 127(3):616-9. PubMed ID: 22940487
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.
Santin AD; Bellone S; Siegel ER; Palmieri M; Thomas M; Cannon MJ; Kay HH; Roman JJ; Burnett A; Pecorelli S
Am J Obstet Gynecol; 2005 Mar; 192(3):813-8. PubMed ID: 15746676
[TBL] [Abstract][Full Text] [Related]
10. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
Clarke MA; Devesa SS; Harvey SV; Wentzensen N
J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
[TBL] [Abstract][Full Text] [Related]
11. Contribution of socioeconomic status to black/white differences in cancer incidence.
McWhorter WP; Schatzkin AG; Horm JW; Brown CC
Cancer; 1989 Mar; 63(5):982-7. PubMed ID: 2914303
[TBL] [Abstract][Full Text] [Related]
12. Determinants of black/white differences in colon cancer survival.
Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
[TBL] [Abstract][Full Text] [Related]
13. Significance of uterine corpus tumor invasion in early-stage cervical cancer.
Matsuo K; Machida H; Blake EA; Takiuchi T; Mikami M; Roman LD
Eur J Surg Oncol; 2017 Apr; 43(4):725-734. PubMed ID: 28215507
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
[TBL] [Abstract][Full Text] [Related]
15. Black race independently predicts worse survival in uterine carcinosarcoma.
Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of adenocarcinoma histology in women with cervical cancer.
Galic V; Herzog TJ; Lewin SN; Neugut AI; Burke WM; Lu YS; Hershman DL; Wright JD
Gynecol Oncol; 2012 May; 125(2):287-91. PubMed ID: 22266551
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic factors and cancer incidence among blacks and whites.
Baquet CR; Horm JW; Gibbs T; Greenwald P
J Natl Cancer Inst; 1991 Apr; 83(8):551-7. PubMed ID: 2005640
[TBL] [Abstract][Full Text] [Related]
18. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001-2003.
Sabatino SA; Stewart SL; Wilson RJ
J Womens Health (Larchmt); 2009 Mar; 18(3):285-94. PubMed ID: 19231990
[TBL] [Abstract][Full Text] [Related]
20. Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors.
Zhang MM; Cheung MK; Osann K; Lee MM; Gomez SS; Whittemore AS; Husain A; Teng NN; Chan JK
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):329-35. PubMed ID: 16449120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
